The main goal of the Dystonia Coalition is to facilitate collaborations that advance the pace of clinical and translational research for isolated dystonia syndromes, previously known as ?primary? dystonias. The Dystonia Coalition includes multiple investigators at 49 different centers in North America, Europe, Israel, and Australia. They work together with several patient advocacy groups through the Administrative Unit on 4 main Clinical Projects, a Pilot Projects Program, and a Career Enhancement Program. The main objectives are to delineate the phenotypic heterogeneity and natural history of the isolated dystonia syndromes, to delineate individual temporal variations in response to current treatments, to develop objective measures for monitoring severity, and to establish a biorepository for exploring biomarkers. The Administrative Unit will be responsible for the overall direction and coordination of the program including coordination of its activities, ensuring effective communication among all of its components, monitoring progress towards objectives, and maintaining a system for fiscal accountability and resource allocation.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54TR001456-09
Application #
9798498
Study Section
Special Emphasis Panel (ZTR1)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
9
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Scorr, Laura M; Silver, Michael R; Hanfelt, John et al. (2018) Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia. Neurotherapeutics 15:452-458
Morris, Aimee E; Norris, Scott A; Perlmutter, Joel S et al. (2018) Quantitative, clinically relevant acoustic measurements of focal embouchure dystonia. Mov Disord 33:449-458
Jinnah, H A; Hess, Ellen J (2018) Evolving concepts in the pathogenesis of dystonia. Parkinsonism Relat Disord 46 Suppl 1:S62-S65
Cotton, Adam C; Bell, R B; Jinnah, H A (2018) Expert Opinion vs Patient Perspective in Treatment of Rare Disorders: Tooth Removal in Lesch-Nyhan Disease as an Example. JIMD Rep 41:25-27
Jinnah, H A; Comella, Cynthia L; Perlmutter, Joel et al. (2018) Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy? Toxicon 147:89-95
Jinnah, H A; Albanese, Alberto; Bhatia, Kailash P et al. (2018) Treatable inherited rare movement disorders. Mov Disord 33:21-35
Shi, Lucy L; Simpson, C Blake; Hapner, Edie R et al. (2018) Pharyngeal Dystonia Mimicking Spasmodic Dysphonia. J Voice 32:234-238
Liu, Hui; Jin, Hongjun; Luo, Zonghua et al. (2018) In Vivo Characterization of Two 18F-Labeled PDE10A PET Radioligands in Nonhuman Primate Brains. ACS Chem Neurosci 9:1066-1073
Sedov, Alexey; Popov, Valentin; Shabalov, Vladimir et al. (2017) Physiology of midbrain head movement neurons in cervical dystonia. Mov Disord 32:904-912
Shaikh, Aasef G; Factor, Stewart A; Juncos, Jorge (2017) Saccades in progressive supranuclear palsy - maladapted, irregular, curved, and slow. Mov Disord Clin Pract 4:671-681

Showing the most recent 10 out of 110 publications